CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Salix Pharmaceuticals, Inc. v. Taro Pharmaceuticals U.S.A., Inc.

1:15-cv-00900

Overview

Case Number 1:15-cv-00900
Filing Date 2015-10-08
Status Terminated
Termination Date 2017-07-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Taro Pharmaceutical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Taro Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

1 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Plaintiff

Norgine B.V. NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Salix Pharmaceuticals, Inc. Operating Company

Represented By

1 Attorneys Listed

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): GB πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7169381
Colon cleansing compositions and methods
Filed: 2003-10-24
Issued: 2007-01-30
Expired (Term Ended) +313d PTA
Expires: 2024-09-01
US7658914
Colon cleansing compositions
Filed: 2006-12-08
Issued: 2010-02-09
Expiring Soon (18 days)
Expires: 2026-12-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+313 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 4

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME Answer to Complaint to January 28, 2016 - filed by Norgine B.V., Salix Pharmaceuticals, Inc.. (Bourke, Mary) (Entered: 01/07/20...
Entry #10 • 2016-01-07 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 10 Joint STIPULATION TO EXTEND TIME Answer to Complaint to January 28, 2016 filed by Salix Pharmaceuticals, Inc., Norgine B.V., Set/Reset Answer ...
Entry #β€” • 2016-01-07
Procedural / Extension Motion Pending
SO ORDERED, re 8 STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to January 8, 2016 filed by Taro Pharmaceu...
Entry #β€” • 2015-11-10
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the Complaint to January 8, 2016 - filed by Taro Pharmaceuticals U.S.A., ...
Entry #8 • 2015-11-09 Document →

Docket Entries

(41 total)
Pleading / Complaint

COMPLAINT filed against Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1804906.) - filed by Salix Pharmaceuticals, Inc., Norgine B.V.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(sar) (Entered: 10/08/2015)

Entry #1 • 2015-10-08
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 10/08/2015)

Entry #2 • 2015-10-08
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/26/15. Date of Expiration of Patent: 9/1/24.Thirty Month Stay Deadline: 2/26/2018. (sar) (Entered: 10/08/2015)

Entry #3 • 2015-10-08
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,169,381; 7,658,914;. (sar) (Entered: 10/08/2015)

Entry #4 • 2015-10-08
1

Disclosure Statement pursuant to Rule 7.1: identifying corporate parents Salix Pharmaceuticals, Ltd and Valeant Pharmaceuticals International, Inc. for Salix Pharmaceuticals, Inc. filed by Salix Pharmaceuticals, Inc. (Entered: 10/08/2015)

Entry #5 • 2015-10-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc